Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
ChemistrySelect. 2022 Aug 5; 7(29): e202201504.
Published online 2022 Aug 1. doi: 10.1002/slct.202201504
PMCID: PMC9538075
PMID: 36247410

Structural and Molecular Packing study of Three New Amidophosphoric Acid Esters and Assessment of Their Inhibiting Activity Against SARS‐CoV‐2 by Molecular Docking

Associated Data

Supplementary Materials
Data Availability Statement

Abstract

Three new compounds of amidophosphoric acid esters with a [OCH2C(CH3)2CH2O]P(O)[X] segment (where X=cyclopentylamido (1), 2‐aminopyridinyl (2) and pyrrolidinyl (3)) were synthesized and studied using FT‐IR and 31P/13C/1H NMR spectroscopies and single‐crystal X‐ray diffraction analysis. The compounds crystallize in the triclinic space groups P 1 for 1 and 3 and in the orthorhombic space group Pca21 for 2, where the asymmetric unit consists of three symmetrically‐independent molecules for 1 and one molecule for 2 and 3. The intermolecular interactions and supramolecular assemblies are assessed by Hirshfeld surface analysis and enrichment ratios. The results reveal that the substituent effect plays an important role in directing the supramolecular structures. The presence of the aromatic substituent aminopyridine in 2 providing the C−H…π interactions leads to a larger variety in interactions including H…H, H…O/O…H, H…C/C…H and H…N/N…H contacts, whereas the packings of the compounds 1 and 3 bearing aliphatic substituents only include H…H and H…O/O…H contacts. The enrichment ratios affirm the importance of O…H/H…O contacts reflecting the hydrogen bond N−H…O interactions to be the enriched contacts. Compounds 1–3 were also investigated along with five similar reported structures with a [OCH2C(CH3)2CH2O]P(O) segment for their inhibitory behavior against SARS‐CoV‐2. The molecular docking results illustrate that the presence of the aromatic amido substituent versus the aliphatic type provides a more favorable condition for their biological activities.

Keywords: Amidophosphoric acid ester, X-ray crystallography, Hirshfeld surface analysis, Molecular docking study, SARS-CoV-2 inhibitor

Crystal structures and packing features of three new amidophosphoric acid esters are studied by single‐crystal X‐ray diffraction and Hirshfeld surface analysis. The studied compounds are also investigated along with five similar reported structures for their inhibitory behavior against SARS‐CoV‐2 by the molecular docking simulation, where the aromatic amido substituents provide a more favorable condition for their biological activities.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g008.jpg

Introduction

Amidophosphoric acid esters are attractive as bioactive agents due to their structural properties allowing them to interact with various living systems. They can be employed as nucleotide prodrugs and antitumor, anticancer or antiviral agents.[ 1 , 2 , 3 , 4 ] The design of new materials with biological applications requires a suitable insight of various intermolecular interactions within a biotic environment such as an active site of an enzyme. [5] In the context of this study it is of relevance that amidophosphoric acid esters can inhibit urease and acetylcholinesterase enzymes.[ 6 , 7 ]

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) has since its appearance in 2019 attracted extensive research towards the development of effective medication against its consequences on human health, but no approved and decisive drug is known until now to treat this virus.[ 8 , 9 ] Clinical trials of new anti‐coronavirus drugs request a long time and equipment; therefore computer‐aided drug discovery such as molecular docking simulation which tests the binding interactions between the target protein of virus and the tested drug compound are being used to evaluate the activity of a drug and to accelerate the choice of potential drugs for clinical trials.[ 10 , 11 ] Some suitable antiviral drugs based on phosphoramides and phosphonates such as Tenofovir, Sofosbuvir and Remdesivir have been proposed as anti‐coronavirus agent.[ 12 , 13 , 14 , 15 ] Moreover, some phosphates‐based compounds were suggested as possible inhibitors against SARS‐CoV‐2. [16] There are, however, no reports of amidophosphoric acid esters as a sub‐class of phosphoramides to evalute their inhibitory effect on coronavirus.

The investigation of various intermolecular interactions of potential drug compounds is of paramount importance to identify the key interactions between the target biological molecular structure and that of the drug compound.[ 17 , 18 ] The various intermolecular interactions in the structures of amidophosphoric acid esters have been investigated before in the presence or absence of N−H…O hydrogen bond.[ 19 , 20 ] The formation of 3D architectures in their molecular aggregations via weak interactions such as π‐effects contacts and non‐covalent forces has also been considered.[ 19 , 21 ]

With this insight in mind, we present in this study the structures of three new amidophosphoric acid esters, [OCH2C(CH3)2CH2O]P(O)[X], (X=HNC5H9 (1), NHC5H4N (2) and NC4H8 (3)) (Scheme 1) determined from single‐crystal X‐ray crystallography. The spectroscopic properties of these compounds are investigated by FT‐IR and 1H/13C/31P‐NMR spectroscopy. The various intermolecular interactions and features of the supramolecular assemblies are examined by 3D Hirshfeld surface maps and 2D fingerprint plots along with the calculated enrichment ratios. This allows us to give a detailed evaluation of the types of interactions and forces which stabilize the structures. Furthermore, a molecular docking study is presented to investigate the inhibitory effect of 1–3 and five similar compounds including the same [OCH2C(CH3)2CH2O]P(O) segment against the coronavirus (Main Protease (MPro) of SARS‐COV‐2, 6M03).

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g010.jpg

Chemical structures of compounds 1–3.

Results and discussion

X‐ray crystallography investigations

The compounds crystallize in the triclinic space group P 1 for 1 and 3 and in the orthorhombic space group Pca21 for 2. Details of the crystallographic analyses are summarized in Table 1. The asymmetric unit has three molecules P1, P16 and P31 in 1 (Figure 1) and one entire molecule in 2 and 3 (Figure 2). The phosphorous atom has in all structures a distorted tetrahedral O=P[−O]2[−N] environment as evidenced from the bond lengths and angles around the P atom (Table S1), being in the same range as in the structures of similar amidophosphoric acid esters[ 19 , 20 ]

Table 1

Crystal data and structure refinement for compounds 1–3.

Compound

1

2

3

CCDC number

2110733

2110734

2110735

Chemical formula

C10H20NO3P

C10H15N2O3P

C9H18NO3P

M r (gr/mol)

233.24

242.22

219.22

Temperature (K)

299

299

300

Crystal system, Space group

Triclinic, P 1

Orthorhombic, Pca21

Triclinic, P 1

a, b, c (Å)

11.5899 (6), 12.0785 (6), 14.9427 (7)

11.0062 (3), 12.6989 (4), 8.8257 (3)

6.4555 (4), 9.5793 (9), 9.6429 (8)

α, β, γ (°)

74.133 (4), 74.025 (4), 69.827 (5)

90, 90, 90

104.041 (7), 91.489 (6), 100.067 (6)

V3)

1850.36 (17)

1233.54 (7)

568.12 (8)

Z

6

4

2

Radiation type

Mo

Mo

Mo

μ (mm−1)

0.21

0.22

0.23

F(000)

756

512

236

Crystal size (mm)

0.35×0.25×0.20

0.21×0.20×0.15

0.45×0.33×0.22

Crystal color/habit

Colorless/Prism

Colorless/Prism

Colorless/Prism

Diffractometer

Xcalibur, Sapphire3, Gemini

Xcalibur, Sapphire3, Gemini

Xcalibur, Sapphire3, Gemini

Theta range for data collection (°)

1.976 to 28.308

2.440 to 27.987

2.278 to 26.671

Absorption correction

Multi‐scan/CrysAlisPRO

Multi‐scan/CrysAlisPRO

Multi‐scan/CrysAlisPRO

T min, T max

0.797, 1.000

0.952, 1.000

0.816, 1.000

No. of measured, independent and observed [I>2.0σ(I)] reflections

45204, 9075, 7006

16957, 3010, 2726

7089, 2669, 2053

R int

0.044

0.040

0.050

(sin θ /λ)max−1)

0.683

0.684

0.682

R[F 2 > 2σ(F 2)], wR(F 2), S

0.063, 0.151, 1.07

0.029, 0.057, 1.11

0.058, 0.162, 1.07

No. of reflections

9075

3010

2669

No. of parameters

439

190

137

No. of restraints

0

1

0

H‐atom treatment

H‐atom parameters constrained

H‐atom parameters constrained

H atoms treated by a mixture of independent and constrained refinement

Δρmax, Δρmin (e.Å−3)

0.48, −0.40

0.14, −0.18

0.41, −0.30

Absolute structure parameter

−0.01 (4)

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g007.jpg

A view of the asymmetric unit of 1, showing three independent molecules P1, P16 and P31 with the atom‐labelling. Displacement ellipsoids are drawn at the 30 % probability level and H atoms are drawn as circles of arbitrary radii.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g003.jpg

Views of Ellipsoid‐style and atom‐labeling presentation of molecular structures of 2 (left) and 3 (right) in the asymmetric unit. The 30 % probability level has been allocated for drawing displacement ellipsoids and H atoms are drawn as circles of arbitrary radii.

The sums of the surrounding angles at the N atoms (∠P−N−C+∠C−N−H+∠P−N−H) in compounds 1 and 2 are slightly deviating from zero: 0.06, 0.03 and 0.21°, for P1, P16 and P31 in 1, and 0.03° in 2 from establishing a mainly sp 2 hybridization for these secondary amines. For compound 3, the sum of the surrounding angles at the tertiary N atom (∠P−N−C+∠P−N−C+∠C−N−C) being 359.99 (18)° confirms a sp 2 character and a planar configuration of this N atom. Such secondary (in 1 and 2) and tertiary (in 3) nitrogen atoms which display a low Lewis‐base character cannot play a role as an acceptor in any hydrogen bond interaction.

In all structures 1–3, the six‐membered ring of the same [OCH2C(CH3)2CH2O]P(O) segment adopts a nearly‐chair conformation. For 2, the P=O bond of this ring is located in an equatorial position (with angles OP=O−P−Oestric=110.92 (7)° and 112.24 (6)°,OP=O−P−N=116.16 (7)° and Oestric−P−N=102.66 (6)° and 108.80 (6)°), whereas for 1 (OP=O−P−Oestric=113.01 (10)° and 114.93 (10)°,OP=O−P−N=114.79 (10)° and Oestric−P−N=104.98 (10)° and 105.71 (10)° for the molecule P1) and 3 (OP=O−P−Oestric=114.80 (10)° and 114.03 (10)°,OP=O−P−N=113.75 (10) ° and Oestric−P−N=105.24 (10)° and 105.33 (11) °), the P=O bond position is intermediate between equatorial and axial. The equatorial position of the P=O bond in 2 may be attributed to the near anti‐orientation of the N−H unit relative to the P=O group and the endo anomeric effect [22] via the n (the non‐bonding orbital of the endocyclic N atom) to σ* (the anti‐bonding orbital of P–Nexocyclic) overlap, as such position of the P=O bond has been observed in the similar diazaphosphorinane ring. [23] In the structures 1 and 2, where the favoured interactions in phosphoramides, i. e. classical N−H…O=P hydrogen bond interaction, are present, a linear framework as a 1D chain building C(4) motif is formed along the [010] and [001] axis, respectively (Table 2, Figure 3). The different syn‐ (in 1) and near anti (in 2)‐orientations of the N−H unit relative to the P=O group form a similar molecular zigzag type arrangement for these 1D chains. However, in the case of 1, the 1D chain is built up by linking three neighbouring symmetry‐independent molecules P1, P16 and P31. This molecular packing formed by the classical N−H…O=P hydrogen bond interaction in 1 and 2 is not found in the structure of 3. Indeed, the oxygen atom of the phosphoryl group in 3 serves as a strong hydrogen‐bonding acceptor. However, all hydrogen atoms are part of methyl and methylene groups and these are consequently the only available hydrogen‐bonding donors which are much weaker than the classical hydrogen‐bond donors. Therefore, in the absence of the favoured donor unit in phosphoramides, i. e. the N−H unit, not any classical hydrogen bond interaction is found in the structure of 3.

Table 2

Hydrogen bond geometry (Å, °) for compounds 1–3.

D−H⋅⋅⋅A

D−H

H⋅⋅⋅A

D⋅⋅⋅A

D−H⋅⋅⋅A

1

N10−H10⋅⋅⋅O39=P31

0.85 (3)

2.13 (2)

2.958 (3)

165 (3)

N25−H25⋅⋅⋅O9=P1

0.85 (3)

2.14 (3)

2.964 (3)

163 (3)

N40−H40⋅⋅⋅O24=P16i

0.86 (4)

2.08 (4)

2.920 (4)

167 (3)

C20−H20b⋅⋅⋅O39=P31ii

1.06 (2)

2.58 (2)

3.576 (4)

156 (6)

C5−H5a⋅⋅⋅O6iii

1.06 (2)

2.61 (1)

3.509 (3)

142 (5)

C5−H5b⋅⋅⋅O24=P16

1.06 (1)

2.60 (1)

3.612 (3)

158 (8)

H13a…H38biv

2.11 (3)

2

N10−H10⋅⋅⋅ O2=P1i

0.99 (2)

1.86 (2)

2.841 (2)

171 (1)

C9−H9 A⋅⋅⋅O3ii

1.05 (3)

2.48 (3)

3.514 (3)

168 (2)

C4−H4B⋅⋅⋅O2=P1ii

1.06 (2)

2.63 (2)

3.525 (2)

142 (1)

C8−H8B⋅⋅⋅O2=P1i

1.02 (2)

2.62 (2)

3.607 (3)

161 (2)

C14−H14⋅⋅⋅O7iii

1.03 (2)

2.52 (2)

3.284 (2)

130 (2)

C13−H13⋅⋅⋅π

2.979

128

C6−H6 A⋅⋅⋅π

2.931

162

3

C6−H6b⋅⋅⋅O2=P1i

1.10 (1)

2.43 (1)

3.421 (3)

149 (1)

C4−H4a⋅⋅⋅O2=P1ii

1.07 (1)

2.43 (1)

3.491 (3)

173 (5)

C4−H4b⋅⋅⋅O2=P1i

1.06 (1)

2.43 (1)

3.407 (2)

151 (8)

Symmetry transformations used to generate equivalent atoms for 1: (i) x, y–1, z, (ii) x, y+1, z, (iii) −x, −y+1, −z+1, (iv) x–1, y, z; for 2: (i) −x+1, −y+1, z12 ; (ii) −x+12 , y, z12 , (iii) x12 , −y+2, z; for 3: (i) −x+1, −y, −z; (ii) x+1, y, z.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g006.jpg

Partial views of the molecular packings of 1 (left) and 2 (right) formed via classical N−H…O=P hydrogen bond. The 1D linear arrangement along the b (for 1) and c (for 2) axis are formed. For 1, the 1D chain is produced by linking of three symmetry‐independent molecules shown by different colors (red, blue and green). The O=P−NH segments involved in hydrogen bonding are shown as ‘ball and sticks’.

Study of the intermolecular interactions and packing features by Hirshfeld surface (HS) analysis

The supramolecular features of the structures 1–3 are studied by using Hirshfeld surface analysis,[ 13 , 33 ] an easy‐to‐operate graphical tool to visually investigate various intermolecular interactions in molecular crystal structures. The graphical 3D Hirshfeld surfaces (HSs) mapped over the d norm parameter and the derived 2D fingerprint plots (FPs) for 1–3 are illustrated in Figures 4 556 and S1, S2, S3. For 2, the HS mapped over the shape index property is shown in Figure 5. The intermolecular contacts and their contribution percentages are also reported in Table 3.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g004.jpg

Views of the d norm Hirshfeld surface maps (up) plotted on the molecule P1 of 1 in two orientations, introducing close contacts, along with the H…H and H…O/O…H fingerprint plots (down).

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g005.jpg

Views of the d norm Hirshfeld (up) and shape index (down) surface maps plotted on the compound 2 in two orientations, introducing close contacts, along with the full fingerprint plot labeling features related to the main intermolecular contacts (down).

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g001.jpg

Views of the d norm Hirshfeld surface maps (up) plotted on the compound 3 in two orientations, introducing close contacts, along with the H…H and H…O/O…H fingerprint plots (down).

Table 3

Data derived from Hirshfeld surface analysis for the compounds 13. The numbers refer to the contribution (in percentage) to the Hirshfeld surface area of the various intermolecular contacts. Contacts with percentage lower than unity are not included.

Contacts

P1 of 1

P16 of 1

P31 of 1

2

3

S X

H

O

C

N

H…H

75.9

73.1

78.0

53.7

75.1

P1

87.60

11.70

H…O/O…H

23.4

26.4

21.4

24.8

24.1

P16

86.30

13.20

H…C/C…H

13.4

P31

88.70

10.70

H…N/N…H

7.6

2

76.60

12.40

6.70

3.80

3

87.15

12.05

Atoms

H

O

H

O

H

O

P1 of 1

R XX/R XY

P16 of 1

R XX/R XY

P31 of 1

R XX/R XY

H

76.74

20.50

H

74.48

22.78

H

78.68

18.98

O

20.50

O

22.78

O

18.98

P1 of 1

E XX/E XY

P16 of 1

E XX/E XY

P31 of 1

E XX/E XY

H

0.99

1.14

H

0.98

1.16

H

0.99

1.13

O

1.14

O

1.16

O

1.13

2

R XX/R XY

H

O

C

N

3

R XX/R XY

H

58.67

19.00

10.26

5.82

H

75.95

21.00

O

19.00

O

21.00

C

10.26

N

5.82

2

E XX/E XY

3

E XX/E XY

H

0.91

1.31

1.31

1.31

H

0.99

1.15

O

1.31

O

1.15

C

1.31

N

1.31

The characteristic red spots near the oxygen atom of the P=O group and the hydrogen atom of the N−H unit in the Hirshfeld surface of the structures 1 and 2 confirm the previously mentioned N−H…O=P classical hydrogen bond. For the molecules P1 and P31 of 1, some little bright red spots on white regions are also seen which are related to H…H contacts (Table 2). The weak C−H…O=P hydrogen bond interactions in 1 and 2 (Table 2) are represented as white regions, while for 2, some of these interactions visible as little pale‐red spots stabilize the structure. In the case of 3, in the absence of the classical N−H…O=P hydrogen bonds, the C−H…O=P hydrogen bond interactions play the important role in the stabilization of the molecular packing and are revealed as red spots. Moreover, for 2 bearing the aromatic substituent pyridine ring, the red π‐hole features on the shape index surface (Figure 5) affirm the presence of π‐effect interactions of the C−H…π type ( Table 2).

In the FPs of 1 and 3, the contributions originate only from H…H and H…O/O…H interactions, where the packing is dominated by H…H contacts, accounting for as high as 76.0 % and 75.0 % of the packing forces in 1 and 3, respectively. The percentage contribution of H…O/O…H contacts to the packing is 23.3 % (for 1) and 24.2 % (for 3). In the case of 2, the largest contribution is found for the H…H contact (53.1 %), followed by the H…O/O…H (25.1 %), H…C/C…H (13.3 %) and H…N/N…H (8.0 %) interactions. The larger variety of contacts in 2, including H…H, H…O/O…H, H…C/C…H and H…N/N…H interactions, compared with 1 and 3 having only H…H and H…O/O…H interactions, can be attributed to the presence of the aromatic substituent aminopyridine which provides the π‐effect C−H…π interactions, i. e. H…C/C…H type contacts. Furthermore, this substituent bearing the nitrogen atom in aromatic ring gives rise to the H…N/N…H contacts.

The combined H…O/O…H contacts for 1 and 2 appear as large symmetrically sharp spikes with minimum values of d i+d e≈2.0 Å for 1 and 1.8 Å for 2, whereas these spikes are small for 3 (d i+d e≥2.4 Å). This result can be attributed to the presence of the classical N−H…O=P hydrogen bond interaction providing the lowest values of d i+d e in 1 and 2 versus the absence of such classical interaction in 3. However, all such close H…O/O…H contacts in 13 are at values less than the sum of the van der Waals (vdW) radii of the oxygen and hydrogen atoms (≈2.7 Å). Moreover, the H…H contact in 1 leads to a sharp spike on the diagonal plot reflecting some short H…H contacts with d i+d e≈2.0 Å which are less than 2×the vdW radius of hydrogen atom (≈2.2 Å).

The wings at the top left and bottom right of the plot of 2 are related to a series of H…C/C…H contacts, while the fraction of these contacts to the packing is 13.3 %. Other regions of the plot are occupied by the H…N/N…H contacts whose fraction to the total surface accounts for only 8.0 %.

Enrichment ratio (EXY)

The propensity of pair atoms (X, Y) to form contacts can be assessed by calculating the enrichment ratios E XY from the Hirshfeld surface fingerprint plots. For a high propensity the X…Y contact is recognized as favored when E>1 and for a low propensity the interaction is disfavored when E<1.[ 24 , 25 ] The enrichment ratios of the compounds 1–3 computed by the results derived from the HS analysis have been given in Table 3.

The results of the enrichment ratios analysis affirm the importance of O…H/H…O contacts including the classical N−H…O=P hydrogen bond interaction in the crystal packings of 1–3 for which these contacts are favored (E OH>1). In contrast, the H…H contacts are disfavored in all three compounds with E HH=0.91–0.99, where the lowest value of E HH is found for 2. As is mentioned above, the presence of the aromatic substituent in the structure of 2 supports the formation of the C…H/H…C and N…H/H…N contacts inside the H…H and O…H/H…O. The existence of such extra contacts in 2 compared with 1 and 3 can underestimate the importance of the H…H contacts in this structure to be completely disfavored. This is in line with the obtained results of the C…H/H…C and N…H/H…N ratios for 2 which are larger than unity (Table 3) and turn out to be enriched.

Molecular docking study

In order to predict the intermolecular framework formed between the studied compounds 13 and the target macromolecular structure generating a binding model, a molecular docking approach was employed. For this study, the small molecules 13 are docked into the target protein 6M03 (Figure 7) to calculate the energetic values at the binding sites, where 6M03 is one of the important proteins which plays a key role in the propagation of the coronavirus. The simulations were done on each of structures selecting the best pose of the compound toward the receptor from the ranking of different poses by the highest negative binding energy. The best ranking binding energies were computed as −6.35, −5.98 and −5.47 kcal/mol for 1–3, respectively. The results show that all studied compounds give efficient binding energy with negative values. These obtained data confirm that the interaction of 1–3 with 6M03 can inhibit the activity of this protein and in result, could prevent the coronavirous function. Thus, amidophosphoric acid esters 13 are potential inhibitors of MPro of SARS‐CoV‐2 to be confirmed by in‐vivo experiments.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g002.jpg

Left: Visual description of the 3‐D compounds 1–3 (up to down, respectively) in the best position relative to 6M03 showing the highest negative binding affinity; Right: The 2D representation maps of 1–3 with amino acid sites inside of the active pocket of 6M03.

Figures 7 and S4 display the various interactions between the compounds 1–3 and the structure of the 6M03 protein. For 1, hydrogen bonding (HB) interactions are formed between the hydrogen atom of NH group and the oxygen atom of the esteric ring with the amino acid residues of GLU A166. The five‐membered ring of amino substituent of 1 interacts with the MET A165, LEU A167 and PRO A168 binding sites. The carbon atoms of the esteric ring also interact with the amino acid residues of MET A165, MET A49, CYS A145, HIS A164 and HIS A41. For 2, the oxygen atom and the carbon atom of the CH3 group of the esteric ring are interacting with CYS A145. An interaction is also found between the aromatic pyridine ring with MET A165. Other observed interactions are formed between the HIS A163 with the CH3 groups of the esteric ring. In the case of 3, the obvious interactions are the HBs formed between the P=O oxygen atom with the LYS A5 and ARG A4 and between the esteric ring with the LEU A282, PHE A3, TRP A207 and PHE A291.

For a detailed investigation, we performed the docking simulations for the main protein of SARS‐CoV‐2 (6M03) on similar compounds 4–8 which have been previously reported[ 19 , 26 , 27 ] using the crystal structure data available in the Cambridge Structural Database (CSD). All these structures are in the family of the amidophosphoric acid ester with a same [OCH2C(CH3)2CH2O]P(O) segment, but with different amino substitutions (Scheme 2). The goal is to investigate the effect of the amino substitions on the biological acivity of these such structures. The molecular docking figures of 1–8 are shown in Figs. S4 and S5, and the related data reported in terms of binding energy (kcal/mole) are summarized in Table 4.

An external file that holds a picture, illustration, etc.
Object name is SLCT-7-0-g009.jpg

Chemical structures of the selected compounds 18 for docking simulation.

Table 4

Resulted parameters (kcal/mol) from interaction between ligand and main protease of Autodock 4.2 for the compounds 1–8.

Compound

1

2

3

4

5

6

7

8

Affinity energy

−6.35

−5.98

−5.47

−6.15

−5. 90

−5.68

−5.13

−5.86

The largest negative binding energies are found for compounds 1, 2, 4, 5 and 8, respectively, where for compounds 2 and 8, the aromatic substituent comes into play in the amino segment. Compound 2 bearing the nitrogen atom at the aromatic pyridine ring has a slightly higher binding energy of 0.08 kcal/mole compared to that of 8. The lowest negative binding energy is for compound 7 bearing the small aliphatic amino substituent with a different value of 1.22 kcal/mole compared to the highest value in 1. Thus one may conclude that the presence of the aromatic substituents in the amido segment of the studied amidophosphoric acid esters provides a more favorable condition for their biological activities than those bearing the aliphatic amido substituents. Similar results have been obtained in a molecular docking study of some phosphoric triamides, where compounds bearing the aromatic substituents illustrated more negative binding affinity energies compared to those having only aliphatic substituents. [14]

Moreover, a comparison of the various interactions between the compounds 1–8 (Figure S4 and S6) and the structure of the 6M03 protein illustrates that the phosphoryl group is involved in an interaction with some amino acid residues of 6M03 for more compounds. The methyl groups of the esteric ring of structures for all compounds are connected to some amino acid residues of protein by various interactions, and for those including the NH group, amino acid residues of the protein are taking part in interactions with the NH group. However, in the case of the binding energy values of compounds with or without the NH group, one cannot find a specific trend.

IR and NMR study

The presence of the N−H units in 1 and 2 is reflected in the IR spectra at 3200 cm−1 and 3161 cm−1, respectively, defining the stretching mode of the N−H unit. Strong bonds related to the P=O stretching modes are found at 1225, 1251 and 1267 cm−1, respectively, for 1–3, which is in agreement with those observed in similar compounds. [28] P−N frequencies are recorded at 822, 787 and 825 cm‐1, respectively for 13.

The chemical shifts of 4.25, −6.65 and 3.36 ppm as singlet signals are found in 31P NMR spectra, respectively for 1–3. The 31P signal of 2 is upfield shifted relative to those in 1 and 3 which can be attributed to a larger electronegativity of the phosphorous atom in 2 by the presence of a pyridine ring which is absent in the structures of 1 and 3.

In the 1H NMR spectra of 1–3, the CH3 protons of six‐membered ring are observed as two singlet signals in the range 0.85–1.15 ppm. For 1 and 2, the CH2 protons of six‐membered ring are found as two multiplet peaks at 3.81/3.97 and 3.90/4.17 ppm, respectively, whereas for 3, a multiplet peak at 3.09 ppm is assigned to the CH2 protons. The related carbon atoms of the CH3 groups of six‐membered ring appear as two singlet signals at the range 19.97–21.45 ppm and the carbon atoms of the CH2 groups are found as a doublet signal at about 75 or 77 ppm with 2 J(P,C)=5.7 or 6.8 Hz. The C(CH3)2 carbon atom is observed as a doublet signal at about 31 ppm with 3 J(P,C)=5.1 or 6.8 Hz.

For 1, other chemical shifts of 1H are at 1.58, 1.73, 3.81 and 3.97 ppm as four multiplet peaks which are related to the CH2 protons of the five‐membered ring. The CH proton of five‐membered ring also appears as a multiplet peak at 5.14 ppm. This spectrum shows a multiplet signal at 3.40 ppm related to the NH proton. In the 13C NMR spectrum of 1, the carbon atoms of the CH2 groups of five‐membered ring are found as two singlet signals at 22.86 and 52.64 ppm, and as a doublet signal at 34.06 ppm with 3 J(P,C)=6.0 Hz.

For 2, the 1H NMR spectrum shows a multiplet peak at the chemical shift of 4.20 ppm for the N−H proton and the aromatic hydrogens appear as four multiplet peaks in the range 6.88–8.74 ppm. In the 13C NMR spectra, the doublet signals at 110.98 ppm (3 J(C,P)=7.8 Hz) and 154.19 ppm (2 J(C,P)=2.6 Hz) and also, singlet signals at 116.56, 138.07 and 147.71 ppm correspond to the related aromatic carbon atoms

For the 1H NMR spectrum of 3, the multiplet signals at 1.76, 3.79 and 4.06 ppm are assigned to the pyrrolidinyl ring protons. The related carbon atoms of the pyrrolidinyl ring in the 13C NMR spectrum are present as two doublet peaks at 25.85 ppm (3 J(C,P)=9.3 Hz) and 46.07 ppm (2 J(C,P)=5.1 Hz).

Conclusions

In summary, we have reported three new amidophosphoric acid ester compounds 1–3, with the same [OCH2C(CH3)2CH2O]P(O) segment investigated by spectroscopic and single crystal X‐ray diffraction methods. A study of the supramolecular assemblies by using X‐ray diffraction and Hirshfeld surface analysis gives a suitable insight of the molecular packing of these compounds. The H…H and H…O/O…H contacts are responsible for the molecular aggregations in the packing of 1–3. However, for 2, bearing the aminopyridine aromatic substituent, the contacts expand to H…C/C…H and H…N/N…H besides the H…H and H…O/O…H contacts attributed to the substituent effect. The importance of O…H/H…O contacts including the classical N−H…O=P hydrogen bond interaction in the crystal packings is affirmed by the results of enrichment ratios which show these contacts to be favoured (E OH>1). A biological simulation based on the molecular docking method on the compounds 1–3 and five similar compounds reveals a favourable potentiality to inhibit the Mpro of SARS‐CoV‐2, where the aromatic amido substituents in such compounds increase their biological activities.

Experimental

Spectroscopy

Infrared (IR) spectra were prepared by using a Bruker ALPHA FT‐IR spectrometer by a KBr disk. 1H, 13C, 31P{1H} NMR spectra were recorded by a NMR Bruker Avance 300 MHz spectrometers and chemical shifts were determined relative to TMS (for 1H and 13C) and 85 % H3PO4 (for 31P) as external standards.

Syntheses and crystallization

The studied compounds were prepared in a similar method by the treatment of a solution of the commercial starting material ClP(O)[OCH2C(CH3)2CH2O] (2 mmol) in dry acetonitrile (20 ml) with a solution of related amine (4 mmol, cyclopentylamine, 2‐aminopyridine and pyrrolidine, respectively for 1–3) in the same solvent (5 ml) at 273 K. The resulted solution was stirred for about 4 h on the stirrer. Then, the solvent was evaporated and the product was washed with distilled water. Single crystals of all three compounds were grown by slow evaporation at room temperature from a solution of the related compound and mixture solvents of CH3OH/DMF (with volume ratio 3 : 1).

Data for 1: IR (KBr, ῡ, cm 1 ): 3200 (N−H), 2966, 2893, 1454, 1387, 1309, 1225 (P=O), 1182, 1086, 1013, 949, 822 (P−N), 785, 624, 511, 473; 1 H NMR (300.13 MHz, DMSO‐d 6 , 300.0 K): δ=0.87 (s, 3H, CH3), 1.01 (s, 3H, CH3), 1.41 (m, 4H, CH2), 1.58 (m, 2H, CH2), 1.73 (m, 2H, CH2), 3.40 (m, 1H, NH), 3.81 (m, 2H, CH2), 3.97 (m, 2H, CH2), 5.14 (m, 1H, CH); 13 C NMR (75.47 MHz, DMSO‐d 6 , 300.0 K): δ=20.48 (s, 1 C, CH3), 20.97 (s, 1 C, CH3), 22.86 (s, 2 C, cyclopentyl), 31.44 (d, 3 J(C,P)=5.1 Hz, 1 C, C(CH3)2), 34.06 (d, 3 J(C,P)=6.0 Hz, 2 C, cyclopentyl), 52.64 (s, 1 C, cyclopentyl), 75.23 (d, 2 J(C,P)=5.7 Hz, 2 C, 2CH2); 31 P{1H} NMR (121.49 MHz, DMSO‐d 6 , 300.0 K): δ=4.25 (s).

Data for 2: IR (KBr, ῡ, cm 1 ): 3161 (N−H), 2968, 1612, 1597, 1475, 1309, 1251 (P=O), 1215, 1063, 1010, 943, 860, 833, 787 (P−N), 623, 511, 486; 1 H NMR (300.13 MHz, DMSO‐d 6 , 300.0 K): δ=0.85 (s, 3H, CH3), 1.15 (s, 3H, CH3), 3.90 (m, 2H, CH2), 4.17 (m, 2H, CH2), 4.20 (m, 1H, NH), 6.88 (m, 2H, Ar), 7.61 (m, 1H, Ar), 8.15 (m, 1H, Ar), 8.74 (s, 1H, Ar); 13 C NMR (75.47 MHz, DMSO‐d 6 , 300.0 K): δ=19.97 (s, 1 C, CH3), 21.45 (s, 1 C, CH3), 31.73 (d, 3 J(C,P)=6.8 Hz, 1 C, C(CH3)2), 77.03 (d, 2 J(C,P)=6.8 Hz, 2 C, 2CH2), 110.98 (d, 3 J(C,P)=7.8 Hz, 1 C, Ar), 116.56 (s, 1 C, Ar), 138.07 (s, 1 C, Ar), 147.71 (s, 1 C, Ar), 154.19 (d, 2 J(C,P)=2.6 Hz, 1 C, Ar); 31 P{1H} NMR (121.49 MHz, DMSO‐d 6 , 300.0 K): δ=–6.65 (s).

Data for 3: IR (KBr, ῡ, cm 1 ): 2986, 2846, 1477, 1348, 1267 (P=O), 1207, 1114, 1055, 1009, 970, 922, 874, 825 (P−N), 808, 635, 563, 490, 432; 1 H NMR (300.13 MHz, (DMSO‐d 6 , 300.0 K): δ=0.85 (s, 3H, CH3), 1.07 (s, 3H, CH3), 1.76 (m, 4H, CH2 of pyrrolidinyl ring), 3.09 (m, 4H, CH2), 3.79 (m, 2H, CH2 of pyrrolidinyl ring), 4.06 (m, 2H, CH2 of pyrrolidinyl ring); 13 C NMR (75.47 MHz, DMSO‐d 6 , 300.0 K): δ=20.17 (s, 1 C, CH3), 21.07 (s, 1 C, CH3), 25.85 (d, 3 J(C,P)=9.3 Hz, 2 C, pyrrolidinyl ring), 31.46 (d, 3 J(C,P)=5.1 Hz, 1 C, C(CH3)3), 46.07 (d, 2 J(C,P)=5.1 Hz, 2 C, pyrrolidinyl ring), 75.37 (d, 2 J(C,P)=5.7 Hz, 2 C, 2CH2); 31 P{1H} NMR (121.49 MHz, DMSO‐d 6 , 300.0 K): δ=3.36 (s).

Crystal structure determination

The details of the crystal data, data collection and structure refinements of 1–3 are given in Table 1. All three measurements were performed on an Rigaku Oxford Diffraction Gemini diffractometer with graphite monochromated Mo Kα radiation (λ=0.71073 Å) using a Sapphire3 CCD detector. Frame integration, scaling and absorption correction using redundant reflections was carried out with CrysAlisProint [29] The structures were solved using the charge‐flipping method from Superflip program [30] with default parameters described elsewhere. [31] The CRYSTALS program [32] and OLEX2 programs [33] were used for the structural refinements. The three structures were refined using two different approaches, one with spherical form factors and the other with aspherical form factors for so‐called Hirshfeld atom refinements (HARs) [34] in which electron densities are determined from molecular wavefunctions calculated by quantum mechanical methods and then partitioned into atomic Hirshfeld electron density functions. [35] The calculation of the wavefunctions on the PBE level with a def2‐TZVPP basis set and a high SCF convergence threshold were done with the ORCA program.[ 36 , 37 , 38 ] The essential step of HAR is to perform a Fourier transformation of the Hirshfeld electron density functions to obtain the related aspherical atomic form factors that are used in the subsequent least‐squares refinements. The NoSpherA2 module in OLEX2 was used for the aspherical form factor refinements. [39]

For the refinements with spherical form factors H atoms were all located in a difference map, but those attached to carbon atoms were repositioned geometrically. The H atoms were initially refined with soft restraints on the bond lengths and angles to regularize their geometry (C−H in the range 0.93–0.98 Å and N−H in the range 0.86–0.89 Å) and U iso(H) (in the range 1.2–1.5 times U eq of the parent atom), after which the positions were refined with riding constraints. [40]

The structures refined with aspherical form factors were used as starting point for HAR. It was not possible to refine all hydrogen positions completely freely and for a number of these distance restraints set at their approximate neutrons values were used during the refinements. The atomic displacement parameters were refined isotropically. R F improved in all cases slightly. The final HARed structures were used for the molecular docking studies as it is believed that these give more accurate binding energies than the structures refined with spherical form factors. [15] The molecular graphics were drawn by using the programs PLATON [41] and Mercury. [42]

Hirshfeld surface analysis

The software package Crystal Explorer 17.5 [43] was utilized to draw the colored graphical maps (Hirshfeld surfaces (HSs)) and plots (fingerprint plots (FPs)) by using the crystallographic information file (CIF) as input. Herein, the HSs are generated based on the d norm distance, a symmetric function of distances from the internal (d i) and external (d e) atoms, and shape index.[ 44 , 45 ] The FPs are derived from HS as a 2D grid formed by (d i, d e) pairs to facilitate the study of intermolecular interactions. Moreover, the enrichment ratio (E) calculations resulted from the collected data from Hirshfeld surface analysis is employed for a detailed evaluation of the intermolecular contacts.[ 25 , 46 ]

Molecular docking procedure

The inhibitory effect of the studied compounds 1–3 against the target protein 6M03 (Protein Data Bank identifier; Main Protease (MPro) of SARS‐CoV‐2) are investigated by blind molecular docking simulation and the calculated binding energy. The X‐ray crystal structure of the 6M03 without any ligand is retrieved from the PDB Data Bank. The software of AutoDock 4.2 [47] with AutoGrid 4 was utilized for these calculations. The biological results were obtained by driving the molecular docking and the best position related to ligand and target providing the lowest energy was selected. Heteroatoms and water molecules of the structure of 6M03 were removed using AutoDock tools and hydrogen atoms were placed automatically in the structure of this stripped version of 6M03. All the docking simulations were generated by using a grid box with 100×100×126 Å points and a grid‐point spacing of 0.375 Å. The number of evaluations and genetic algorithm runs were set to 100 using a Lamarckian genetic algorithm method. The 2D ligand maps were also generated by the Discovery studio software. [48]

Supporting Information Summary

Supporting information includes Table S1 (selected bond lengths and angles for 1–3) and Figures S1–S6 (Hirshfeld surface and molecular docking results for the studied compounds).

X‐ray crystallography

Deposition Numbers 2110733–2110735, respectively for compounds 13 contain the supplementary crystallographic data for this paper. These data are provided free of charge by the joint Cambridge Crystallographic Data Center via http://www.ccdc.cam.ac.uk/structures/access structures service.

Conflict of interest

The authors declare no conflict of interest.

1. 

Supporting information

As a service to our authors and readers, this journal provides supporting information supplied by the authors. Such materials are peer reviewed and may be re‐organized for online delivery, but are not copy‐edited or typeset. Technical support issues arising from supporting information (other than missing files) should be addressed to the authors.

Supporting Information

Acknowledgements

Support of this investigation by Semnan University is gratefully acknowledged.

Notes

N. Heidari, A. Tarahhomi, A. van der Lee, ChemistrySelect 2022, 7, e202201504.

Data Availability Statement

The data that support the findings of this study are available in the supplementary material of this article.

References

1. Freel Meyers C. L., Hong L., Joswig C., Borch R. F., J. Med. Chem. 2000, 43, 4313–4318. [PubMed] [Google Scholar]
2. Abraham T. W., Kalman T. I., McIntee E. J., Wagner C. R., J. Med. Chem. 1996, 39, 4569–4575. [PubMed] [Google Scholar]
3. Zhang W., Fan W., Zhou Z., Garrison J., ACS Med. Chem. Lett. 2017, 8, 1269–1274. [PMC free article] [PubMed] [Google Scholar]
4. Venkatachalam T., Samuel P., Qazi S., Uckun F., Bioorg. Med. Chem. 2005, 13, 5408–5423. [PubMed] [Google Scholar]
5. Carletti E., Colletier J.-P., Schopfer L. M., Santoni G., Masson P., Lockridge O., Nachon F., Weik M., Chem. Res. Toxicol. 2013, 26, 280–289. [PubMed] [Google Scholar]
6. Domínguez M. J., Sanmartín C., Font M., Palop J. A., San Francisco S., Urrutia O., Houdusse F., García-Mina J. M., J. Agric. Food Chem. 2008, 56, 3721–3731. [PubMed] [Google Scholar]
7. Gholivand K., Valmoozi A. A. E., Bonsaii M., Pestic. Biochem. Physiol. 2014, 112, 40–50. [PubMed] [Google Scholar]
8. Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., The Lancet 2020, 395, 497–506. [PMC free article] [PubMed] [Google Scholar]
9. Lassoued A., Saad A. B., Lassoued H., Ketata R., Boubaker O., MedRxiv 2020, PPR:R155789. [Google Scholar]
10. Al-Karmalawy A. A., Dahab M. A., Metwaly A. M., Elhady S. S., Elkaeed E. B., Eissa I. H., Darwish K. M., Front. Chem. 2021, 9, 661230. [PMC free article] [PubMed] [Google Scholar]
11. Sliwoski G., Kothiwale S., Meiler J., Lowe E. W., Pharmacol. Rev. 2014, 66, 334–395. [PMC free article] [PubMed] [Google Scholar]
12. Elfiky A. A., Life Sci. 2020, 253, 117592. [PMC free article] [PubMed] [Google Scholar]
13. Gholivand K., Barzegari A., Mohammadpanah F., Yaghoubi R., Roohzadeh R., Valmoozi A. A. E., Polyhedron 2022, 221, 115824. [PMC free article] [PubMed] [Google Scholar]
14. Gholamnezhad E., Tarahhomi A., van der Lee A., J. Mol. Struct. 2022, 1259, 132742. [PMC free article] [PubMed] [Google Scholar]
15. Najarianzadeh M., Tarahhomi A., Pishgo S., van der Lee A., Appl. Organomet. Chem. 2022, 36, e6636. [PMC free article] [PubMed] [Google Scholar]
16. Marciniec K., Chrobak E., Dąbrowska A., Bębenek E., Kadela-Tomanek M., Pęcak P., Boryczka S., Biomol. Eng. 2020, 10, 1148. [PMC free article] [PubMed] [Google Scholar]
17. Spackman P. R., Yu L. J., Morton C. J., Parker M. W., Bond C. S., Spackman M. A., Jayatilaka D., Thomas S. P., Angew. Chem. Int. Ed. Engl. 2019, 131, 16936–16940. [PubMed] [Google Scholar]
18. Veljkovic N., Glisic S., Perovic V., Veljkovic V., Expert Opin. Drug Discovery 2011, 6, 1263–1270. [PubMed] [Google Scholar]
19. Bozorgvar M. S., Tarahhomi A., van der Lee A., Z. Kristallogr.-Cryst. Mater. 2020, 235, 69-84. [Google Scholar]
20. Pourayoubi M., Nečas M., Negari M., Acta Crystallogr. Sect. C 2012, 68, o51-o56.. [PubMed] [Google Scholar]
21. Tarahhomi A., Pourayoubi M., Golen J. A., Zargaran P., Elahi B., Rheingold A. L., Ramírez L., Mancilla Percino T., Acta Crystallogr. Sect. B 2013, 69, 260–270. [PubMed] [Google Scholar]
22. Bentrude W. G., Setzer W. N., Ramli E., Khan M., Sopchik A. E., J. Org. Chem. 1991, 56, 6127–6131. [Google Scholar]
23. Tarahhomi A., Pourayoubi M., Rheingold A. L., Golen J. A., Struct. Chem. 2011, 22, 201–210. [Google Scholar]
24. Spackman M. A., McKinnon J. J., CrystEngComm 2002, 4, 378–392. [Google Scholar]
25. Jelsch C., Ejsmont K., Huder L., IUCrJ 2014, 1, 119–128. [PMC free article] [PubMed] [Google Scholar]
26.  
26a. Cameron T. S., Karolak-Wojciechowska J., Acta Crystallogr. Sect. B 1977, 33, 2342–2344; [Google Scholar]
26b. Cameron T. S., Gałdecki Z., Karolak-Wojciechowska J., Acta Crystallogr. Sect. B 1976, 32, 492–496. [Google Scholar]
27. Bozorgvar M. S., Tarahhomi A., van der Lee A., J. Mol. Struct. 2021, 1223, 128942. [Google Scholar]
28. Tarahhomi A., van der Lee A., Ośmiałowski B., Polyhedron 2019, 158, 215–224. [Google Scholar]
29. Agilent, 2011, CrysAlis PRO, Version 1.171.138.143c, Agilent Technologies, YarntoOx- fordshire, England.
30. Palatinus L., Chapuis G., J. Appl. Crystallogr. 2007, 40, 786–790. [Google Scholar]
31. van der Lee A., J. Appl. Crystallogr. 2013, 46, 1306–1315. [Google Scholar]
32. Betteridge P., Carruthers J., Cooper R., Prout K., Watkin D., J. Appl. Crystallogr. 2003, 36, 1487. [Google Scholar]
33. Dolomanov O. V., Bourhis L. J., Gildea R. J., Howard J. A., Puschmann H., J. Appl. Crystallogr. 2009, 42, 339–341. [PMC free article] [PubMed] [Google Scholar]
34.  
34a. Capelli S. C., Bürgi H.-B., Dittrich B., Grabowsky S., Jayatilaka D., IUCrJ 2014, 1, 361–379; [PMC free article] [PubMed] [Google Scholar]
34b. Jayatilaka D., Dittrich B., Acta Crystallogr. Sect. A 2008, 64, 383–393. [PubMed] [Google Scholar]
35. Hirshfeld F. L., Theor. Chim. Acta 1977, 44, 129–138. [Google Scholar]
36. Neese F., Wiley Interdiscip. Rev. Comput. Mol. Sci. 2012, 2, 73-78. [Google Scholar]
37. Neese F., Wiley Interdiscip. Rev. Comput. Mol. Sci. 2018, 8, e1327. [Google Scholar]
38. Neese F., Wennmohs F., Becker U., Riplinger C., J. Chem. Phys. 2020, 152, 224108. [PubMed] [Google Scholar]
39. Kleemiss F., Dolomanov O. V., Bodensteiner M., Peyerimhoff N., Midgley L., Bourhis L. J., Genoni A., Malaspina L. A., Jayatilaka D., Spencer J. L., Chem. Sci. 2021, 12, 1675–1692. [PMC free article] [PubMed] [Google Scholar]
40. Cooper R. I., Thompson A. L., Watkin D. J., J. Appl. Crystallogr. 2010, 43, 1100–1107. [Google Scholar]
41. Spek A. L., Acta Crystallogr. Sect. D 2009, 65, 148–155. [PMC free article] [PubMed] [Google Scholar]
42. Macrae C., Bruno I., Chisholm J., Edgington P., McCabe P., Pidcock E., Rodriguez-Monge L., Taylor R., J. Appl. Crystallogr. 2008, 41, 466–470. [Google Scholar]
43. M. J. Turner, J. J. McKinnon, S. K. Wolff, D. J. Grimwood, P. R. Spackman, D. Jayatilaka, M. A. Spackman, CrystalExplorer 17.5, University of Western Australia, Australia, 2017.
44. McKinnon J. J., Spackman M. A., Mitchell A. S., Acta Crystallogr. Sect. B 2004, 60, 627–668. [PubMed] [Google Scholar]
45. McKinnon J. J., Jayatilaka D., Spackman M. A., Chem. Commun. 2007, 3814–3816. [PubMed] [Google Scholar]
46. Sebghati M., Tarahhomi A., Kozakiewicz A., ChemSelect. 2020, 5, 185–195. [Google Scholar]
47. Morris G. M., Huey R., Lindstrom W., Sanner M. F., Belew R. K., Goodsell D. S., Olson A. J., J. Comput. Chem. 2009, 30, 2785–2791. [PMC free article] [PubMed] [Google Scholar]
48.  
48a. Discovery Studio Modeling Environment. Release 4.5, Dassault Systemes, San Diego, CA, 2015;
48b. Discovery Studio Visualizer, v20.1.0.19259; 2009. Available online: https://discover.3ds.com/discovery-studio-visualizer (accessed on October 2020).

Articles from Chemistryselect are provided here courtesy of Wiley